Home › NDC Lookup › RxCUI directory › RxCUI 310362

Fluocinonide 0.0005 MG/MG Topical Gel — RxCUI 310362

RxNorm drug concept · Semantic clinical drug
RxCUI 310362 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310362
Official nameFluocinonide 0.0005 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluocinonide 0.05 % Topical Gel
FDA products mapped4
Package NDCs mapped12
Reported Medicaid activity (SDUD)31,188 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluocinonide Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It calms redness, swelling and itching from steroid-responsive skin conditions, such as psoriasis and atopic dermatitis. It's for people 12 and older.
  • Use a thin layer on the affected skin only, as your prescriber directs. Psoriasis may be once or twice daily, while atopic dermatitis is once daily. Keep it out of your eyes, mouth...
  • Not longer than 2 consecutive weeks, and stop when your skin is controlled. If you see no improvement in 2 weeks, check back with your doctor.
  • No. Avoid your face, groin and underarms. It also shouldn't be used for rosacea or perioral dermatitis.
📖 Read our full Fluocinonide Topical guide →

🕸️ Concept Web — How Fluocinonide 0.0005 MG/MG Topical Gel Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluocinonide 0.0005 MG/MG Topical Gel RxCUI 310362

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fluocinonide 4462
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluocinonide Topical Gel 379077
    • Fluocinonide Topical Product 1160817
    • Topical Gel 346286
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fluocinonide 0.0005 MG/MG 340004

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluocinonide 0.0005 MG/MG SCDC · 340004
  • Fluocinonide Topical Gel SCDF · 379077
  • Fluocinonide Topical Product SCDG · 1160817

📦 FDA Products & Package NDCs

4 products · 12 package NDCs
12 package NDCs map to RxCUI 310362 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0761-15 1 TUBE in 1 CARTON (45802-761-15) / 15 g in 1 TUBE FLUOCINONIDE Padagis Israel Pharmaceuticals Ltd 2025-04-10
45802-0761-30 1 TUBE in 1 CARTON (45802-761-30) / 30 g in 1 TUBE FLUOCINONIDE Padagis Israel Pharmaceuticals Ltd 2025-04-10
45802-0761-60 1 TUBE in 1 CARTON (45802-761-60) / 60 g in 1 TUBE FLUOCINONIDE Padagis Israel Pharmaceuticals Ltd 2025-04-10
51672-1254-01 1 TUBE in 1 CARTON (51672-1254-1) / 15 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1989-01-19
51672-1254-02 1 TUBE in 1 CARTON (51672-1254-2) / 30 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1989-01-19
51672-1254-03 1 TUBE in 1 CARTON (51672-1254-3) / 60 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1989-01-19
51672-1264-01 1 TUBE in 1 CARTON (51672-1264-1) / 15 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1999-06-30
51672-1264-02 1 TUBE in 1 CARTON (51672-1264-2) / 30 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1999-06-30
51672-1264-03 1 TUBE in 1 CARTON (51672-1264-3) / 60 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1999-06-30
51672-1279-01 1 TUBE in 1 CARTON (51672-1279-1) / 15 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1997-07-29
51672-1279-02 1 TUBE in 1 CARTON (51672-1279-2) / 30 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1997-07-29
51672-1279-03 1 TUBE in 1 CARTON (51672-1279-3) / 60 g in 1 TUBE Fluocinonide Sun Pharmaceutical Industries, Inc. 1997-07-29
Observed labelers: Sun Pharmaceutical Industries, Inc. (9) · Padagis Israel Pharmaceuticals Ltd (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.